Omnipod DASH Insulin Management System User Guide (OUS Only) Product Catalog Number: PT 000002 XXX XXX XX PT 000318 PT 000319 Distributed to: Canada (French only), the Netherlands, France, Austria, Germany, Belgium, Greece, Turkey, Norway, Sweden, Denmark, and Finland
Class I - DangerousWhat Should You Do?
- Check if you have this product: Part Number/Rev./Country: PT 000002 AUT DEU mg 1, 2, 3 Guide, Dash User, German Austria PT 000002 BEL DEU MG 1, 2, 3 Guide, Dash User Guide, Belgium Germany, mgdl PT 000002 BEL FRE MG 1, 2, 3, 4 Guide, Dash User Guide, Belgium French, mgdl PT 000002 BEL NLD MG 1, 2, 3 Guide, Dash User Guide, Belgium Dutch, mgdl PT 000002 DEU DEU mg 1, 2, 3 Guide, Dash User Guide, German Germany, mgdl PT 000002 DEU DEU mm 1, 2, 3 Guide, Dash User Guide, German Germany, mmoll PT 000002 DNK DANmm 1, 2, 3 Guide, Dash User Guide, Danish Denmark PT 000002 FIN FIN mm 1, 2, 3 Guide, Dash User Guide, Finnish Finland PT 000002 FRA FRE mg 1, 2, 3, 4 Guide, Dash User Guide, French France PT 000002 NLD NLD mm 1, 2, 3, 4 Guide, Dash User Guide, Dutch Netherland PT 000002 NOR NORmm 1, 2, 3 Guide, Dash User Guide, Norwegian Norway PT 000002 SWE SWEmm 1, 2, 3 Guide, Dash User Guide, Swedish Sweden 41333 CAN 1, 2 User Guide, Omnipod, Dash, Canada PT 000318 1, 2 Guide, Dash User Guide, Greece PT 000319 1, 2 Guide, Dash User Guide, Turkey
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Insulet Corporation
- Reason for Recall:
- Certain foreign user guides include a misprint which could lead to an incorrect bolus delivery and hypoglycemia. Only Outside the US (OUS): Error in the Omnipod DASH User Guide text, page 6 of the User Guide, the text states that the comma (,) is not used for the decimal on the PDM, when in fact it is the period (.) that is not used.If a user were to use the period as a decimal separator when entering a bolus value, this decimal separator would not be recognized by the device and any numbers entered after the period could result in a larger value than intended
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Omnipod DASH Insulin Management System User Guide (OUS Only) Product Catalog Number: PT 000002 XXX XXX XX PT 000318 PT 000319 Distributed to: Canada (French only), the Netherlands, France, Austria, Germany, Belgium, Greece, Turkey, Norway, Sweden, Denmark, and Finland
Product Codes/Lot Numbers:
Part Number/Rev./Country: PT 000002 AUT DEU mg 1, 2, 3 Guide, Dash User, German Austria PT 000002 BEL DEU MG 1, 2, 3 Guide, Dash User Guide, Belgium Germany, mgdl PT 000002 BEL FRE MG 1, 2, 3, 4 Guide, Dash User Guide, Belgium French, mgdl PT 000002 BEL NLD MG 1, 2, 3 Guide, Dash User Guide, Belgium Dutch, mgdl PT 000002 DEU DEU mg 1, 2, 3 Guide, Dash User Guide, German Germany, mgdl PT 000002 DEU DEU mm 1, 2, 3 Guide, Dash User Guide, German Germany, mmoll PT 000002 DNK DANmm 1, 2, 3 Guide, Dash User Guide, Danish Denmark PT 000002 FIN FIN mm 1, 2, 3 Guide, Dash User Guide, Finnish Finland PT 000002 FRA FRE mg 1, 2, 3, 4 Guide, Dash User Guide, French France PT 000002 NLD NLD mm 1, 2, 3, 4 Guide, Dash User Guide, Dutch Netherland PT 000002 NOR NORmm 1, 2, 3 Guide, Dash User Guide, Norwegian Norway PT 000002 SWE SWEmm 1, 2, 3 Guide, Dash User Guide, Swedish Sweden 41333 CAN 1, 2 User Guide, Omnipod, Dash, Canada PT 000318 1, 2 Guide, Dash User Guide, Greece PT 000319 1, 2 Guide, Dash User Guide, Turkey
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-1203-2021
Related Recalls
Due to a manufacturing defect, certain Omnipod 5 Pods from 49 lots have an internal soft cannula tear that results in insulin leaking into the Pod instead of being delivered to the user regardless of basal or bolus delivery. This defect results from damage to the unexposed portion of the soft cannula during manufacturing, which would result in a compromised fluid path. The primary failure mode is pump under-delivery due to loss of insulin to an internal leak; in some cases, the defect may also lead to pump shutoff and cessation of insulin delivery when leaked insulin contacts Pod circuity in a manner that results in an electrical short. Under-delivery of insulin (both basal and bolus insulin) or cessation of insulin put users at risk of hyperglycemia, and complications from acute and chronic hyperglycemia, including dehydration, blurry vision, nausea, vomiting, altered mental status, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar syndrome (HHS), or even death. Users may require hospitalization or medical intervention to treat severe adverse health consequences. Not all devices with the defect will issue an alarm or alert the user. If there is sufficient leakage of insulin to cause a short in the circuity, the Pod will issue a Hazard Alarm that stops all insulin delivery and alerts the user to replace their Pod. In addition, if a user s glucose is trending high and is not responding to insulin delivery, the system may reach the maximum amount of insulin microboluses allowed by the system and trigger the Automated Delivery Restriction (ADR) alert that tells users to check their blood glucose and take appropriate actions (i.e., ADR is a response to persistent hyperglycemia and maximum automated delivery constraints rather than a direct detection of the leak). The magnitude of under-delivery is unknown and based on multiple factors, including how much insulin is being delivered, whether an alarm and/or alert triggers, whether and when the user recognizes the device defect, the duration of Pod use, and the size of the tear.
The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard. This causes the single digit number to duplicate. This could result in errors in manual entry of digits - examples: bolus entry, I:C ratio, bolus calculator, prior to starting the bolus insulin delivery. Therefore, this may result in over delivery of insulin which may cause hypoglycemia.
Insulet Corporation is recalling Omnipod 5 iOS App, due to a software design issue in which a comma is not recognized as a decimal separator and the user cannot enter a decimal separator in any manual entry screen if the user manually updates their phone settings to a region OUS that uses a decimal separator instead of a period decimal separator or chooses that format as a preference. Use of the affected software may result in over delivery of insulin by increasing the amount of insulin when a decimal separator is not recognized (e.g., 0.1 unit recognized as 1 unit) and thus may result in hypoglycemia, potentially severe.